Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment

Current Drug Targets. Cardiovascular & Haematological Disorders
J G Regensteiner

Abstract

Peripheral arterial disease (PAD), when accompanied by claudication, is a disabling disease that affects 12 percent of the population of the United States (US). PAD is associated with increased mortality as well as decreased functional status and quality of life. Smoking cessation and treatment of diabetes are key aspects of risk factor modification for the PAD patient as well as controlling other cardiovascular risk factors. Typically, only the most severely diseased patients with PAD receive surgery for the indication of claudication and other therapeutic options are being sought. Exciting developments are taking place in the area of drug development for instance. The benefits of a supervised walking exercise program have been consistently demonstrated in persons with PAD and therefore, exercise rehabilitation constitutes an important form of therapy for these persons. Unfortunately, in the US, exercise rehabilitation is not always reimbursed which may lessen its utility presently. All therapies which are used to treat claudication should incorporate measures of functional status and quality of life in addition to treadmill walking in order to ascertain the benefit of a given treatment for patients with PAD.

Citations

Aug 21, 2013·Atherosclerosis·Bethany Barone GibbsKerry J Stewart
Jun 30, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Anna Maria MalagoniFabio Manfredini
Feb 20, 2013·Current Cardiology Reports·Mary McGrae McDermott
Nov 9, 2011·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Marge LovellEd Weiss
Oct 20, 2009·Annales de cardiologie et d'angéiologie·C Voyer
Jun 2, 2015·American Heart Journal·Sreekanth VemulapalliW Schuyler Jones
Oct 10, 2012·Journal of Vascular Surgery·Nicholas J LeeperJohn P Cooke
Feb 14, 2016·Vascular Medicine·Mary M McDermottMichael H Criqui
Mar 11, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Marie Guidon, Hannah McGee
May 23, 2015·Journal of the American Heart Association·Mary M McDermottW Jack Rejeski
May 23, 2014·Journal of the American Heart Association·Mary M McDermottW Jack Rejeski
Jun 28, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Natan D da SilvaEdilamar M de Oliveira
Jun 24, 2016·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Dustin NeffBruno T Roseguini
Jul 1, 2016·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Alisha M KuhlenhoelterBruno T Roseguini
Jun 28, 2007·Vascular and Endovascular Surgery·Ferdinand Serracino-InglottIrwin V Mohan
Nov 5, 2019·International Wound Journal·Cornelius M DonohueLaura L Bolton
May 27, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Fabio ManfrediniPaolo Zamboni
Nov 8, 2020·Annals of Vascular Surgery·Miquel Coca-MartinezHeather L Gill
May 12, 2009·Vascular·Joseph ShalhoubAlun Davies
Aug 22, 2021·Gaceta sanitaria·Anna Ruiz-ComellasMaría Teresa Alzamora-Sas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.